Menu
Surgical Intervention
Major Operative Suite
Major Operative Suite Invasive Expected Stay: 3 Days

Endoscopic Full-Thickness Resection (EFTR)

Protocol / Details

Endoscopic Full-Thickness Resection (EFTR) is a major surgical procedure indicated for the resection of deep-seated subepithelial tumors, non-lifting adenomas, or suspected early-stage malignant lesions. The procedure is performed under general anesthesia in a sterile operating room environment. Using a specialized colonoscope or gastroscope equipped with an endoscopic full-thickness resection device (FTRD), the target lesion is captured into a transparent cap. A circumferential clip is deployed to achieve closure of the defect before the resection is performed using an integrated snare. This ensures full-thickness removal while simultaneously sealing the wall defect to prevent perforation and peritonitis.

Procedure Type
Surgery / Invasive
Estimated Base Cost
Varies by patient
Medical & Surgical Disclaimer The clinical information provided regarding this procedure is for educational purposes only. Only a qualified specialist or surgeon can determine if you are a suitable candidate for this intervention after a thorough examination.

Mandatory overnight fasting (NPO) for at least 8 hours. Comprehensive bowel preparation for colorectal procedures. Pre-operative physical examination, blood coagulation profile assessment, and baseline ECG. Anesthesia consultation to review comorbidities. Prophylactic intravenous antibiotics administration prior to induction.

Post-operative admission to the surgical ward for close observation for signs of peritonitis (fever, abdominal pain, tachycardia). Intravenous fluids and gradual transition to a clear liquid diet within 24 hours. Early mobilization. Follow-up endoscopic surveillance scheduled based on histopathology results. Discharge planned after return of bowel function and clinical stability.

Comprehensive Guide to Endoscopic Full-Thickness Resection (EFTR)

Endoscopic Full-Thickness Resection (EFTR) represents a paradigm shift in minimally invasive gastrointestinal surgery. By bridging the gap between standard endoscopic mucosal resection (EMR) and invasive surgical resection, EFTR allows for the removal of complex lesions that extend into or through the muscularis propria of the gastrointestinal (GI) tract. This guide provides an exhaustive clinical overview for medical professionals, navigating the technical landscape, procedural methodology, and post-operative management of EFTR.


1. Introduction and Clinical Overview

EFTR is an advanced interventional endoscopy technique designed to resect lesions that are technically challenging or impossible to remove via conventional endoscopic methods. Traditionally, lesions involving the deeper layers of the GI wall (such as subepithelial tumors or deep-seated polyps) required laparoscopic or open surgery. EFTR provides a "third space" approach, allowing for the en bloc resection of full-wall layers while maintaining the safety profile of an endoscopic procedure.

The primary objective of EFTR is to achieve R0 resection (microscopically clear margins) for complex lesions, including those with fibrosis, residual disease from prior attempts, or lesions originating from the muscularis propria, all while avoiding the morbidity associated with major abdominal surgery.


2. Technical Specifications and Mechanism

The EFTR procedure typically utilizes a specialized device (most notably the Full-Thickness Resection Device, or FTRD®) that integrates a modified colonoscope with a dedicated applicator.

Key Components of the FTRD System:

  • The Applicator: A transparent cap mounted on the tip of the endoscope, containing a pre-loaded nitinol clip and a thin snare.
  • The Nitinol Clip: A robust, over-the-scope clip (OTSC) that provides full-thickness tissue apposition, ensuring the wall is sealed before the resection occurs.
  • The Snare: A high-frequency snare integrated into the cap for the actual tissue cutting.

The Mechanism of Action:

  1. Tissue Capture: The target lesion is suctioned into the cap.
  2. Wall Apposition: The clip is deployed, encompassing the entire wall thickness (mucosa, submucosa, and muscularis propria) beneath the lesion.
  3. Resection: The integrated snare is tightened above the clip, and high-frequency current is applied to excise the tissue.
  4. Closure: Because the clip was deployed prior to the cut, the wall defect is immediately sealed, preventing perforation and peritonitis.

3. Clinical Indications and Usage

EFTR is indicated for patients with lesions that cannot be managed by standard endoscopic techniques.

Indication Description
Subepithelial Tumors (SETs) Lesions arising from the muscularis propria (e.g., GISTs, leiomyomas).
Recurrent/Residual Adenomas Polyps with significant fibrosis preventing lifting during standard EMR.
Non-lifting Lesions Lesions that demonstrate a negative "lift sign" due to previous scarring or deep invasion.
Early-Stage Malignancy T1 cancers requiring full-thickness assessment for accurate staging.
Diagnostic Tissue Acquisition Full-thickness biopsies for elusive histological diagnoses.

4. Pre-Operative Preparation

Patient selection is the cornerstone of EFTR success. A multidisciplinary team including gastroenterologists, surgeons, and radiologists must evaluate each case.

  • Imaging: Endoscopic Ultrasound (EUS) is mandatory to assess the depth of invasion, the layer of origin, and the relationship to surrounding structures.
  • Bowel Preparation: For colorectal EFTR, a high-volume polyethylene glycol (PEG) preparation is required to ensure a clean field.
  • Anticoagulation: Management of antiplatelet and anticoagulant therapy must follow current guidelines, generally requiring discontinuation 5–7 days prior to the procedure.
  • Informed Consent: Patients must be counseled on the small but inherent risk of incomplete resection and the potential need for urgent surgical conversion.

5. The Procedure: A Step-by-Step Protocol

  1. Endoscopic Assessment: Detailed inspection of the lesion to confirm size (usually <30mm for current FTRD systems) and location.
  2. Marking: If the lesion is large or difficult to visualize, endoscopic tattooing or marking at the periphery may be performed.
  3. Device Loading: The FTRD system is mounted onto the colonoscope.
  4. Suction and Deployment: The lesion is pulled into the cap using suction. The operator must confirm that the target tissue is fully captured within the cap.
  5. Clip Deployment: The trigger wire is pulled to deploy the OTSC.
  6. Resection: The snare is activated using an electrosurgical unit (Endocut mode is typically preferred).
  7. Retrieval: The specimen is retrieved, and the site is inspected to ensure the clip is secure and no active bleeding is present.

6. Post-Operative Recovery and Monitoring

Recovery protocols are generally faster than surgical interventions.

  • Observation: Patients are typically monitored in a recovery area for 2–4 hours.
  • Diet: Patients may resume a clear liquid diet or a light meal depending on the location of the resection and the patient's general tolerance.
  • Medication: Proton pump inhibitors (PPIs) are often prescribed for gastric procedures; analgesics are provided as needed.
  • Discharge: Most patients are discharged on the same day, provided there are no signs of peritonitis or hemodynamic instability.
  • Follow-up: A follow-up colonoscopy/endoscopy is typically scheduled at 6–12 months to verify healing and confirm the absence of recurrence.

7. Risks, Complications, and Contraindications

While EFTR is minimally invasive, it carries specific risks that necessitate clinical vigilance.

Potential Complications:

  • Perforation: While the clip is designed to prevent this, improper application or failure to capture full-thickness tissue can lead to residual leaks.
  • Bleeding: Intra-procedural or delayed post-procedural hemorrhage.
  • Clip-related Issues: Tissue entrapment, clip migration, or interference with later procedures.
  • Infection: Rare, but potential for localized peritonitis if the seal is compromised.

Contraindications:

  • Lesion Size: Lesions >30mm are generally too large for current standard FTRD caps.
  • Location: Extreme proximity to critical structures (e.g., ureters, major vessels) where full-thickness resection poses a risk of collateral damage.
  • Severe Comorbidities: ASA physical status IV patients who cannot tolerate sedation.

8. Alternative Treatments

When EFTR is not viable, clinicians must consider alternative modalities:

  1. Endoscopic Mucosal Resection (EMR): Suitable for superficial lesions that lift well with submucosal injection.
  2. Endoscopic Submucosal Dissection (ESD): Ideal for larger lesions, but requires high technical skill and carries a higher risk of perforation compared to EMR.
  3. Laparoscopic-Endoscopic Cooperative Surgery (LECS): A hybrid approach combining endoscopic resection with laparoscopic guidance, useful for large gastric GISTs.
  4. Surgical Resection: The gold standard for large, invasive, or malignant lesions that are unsuitable for endoscopic management.

9. Frequently Asked Questions (FAQ)

1. How does EFTR differ from ESD?

ESD is designed to dissect within the submucosal plane, whereas EFTR intentionally removes the entire wall thickness, including the muscularis propria, and closes the wall with a clip.

2. Is EFTR a permanent solution?

Yes, for benign tumors and early-stage cancers, EFTR provides a curative, permanent resection.

3. What is the maximum size of a lesion that can be treated?

Standard FTRD devices are typically restricted to lesions of 30mm or smaller due to the size of the applicator cap.

4. Does the clip stay in the body forever?

Yes, the OTSC is permanent. It is made of nitinol and is generally well-tolerated, eventually being covered by mucosal tissue.

5. What happens if the lesion is too large for the cap?

If the lesion exceeds the capacity of the EFTR device, the patient should be referred for LECS or surgical resection.

6. Is general anesthesia required?

EFTR is typically performed under deep sedation (propofol) or general anesthesia, depending on institutional protocols and patient factors.

7. How long does the procedure take?

On average, the procedure takes 30 to 60 minutes, depending on the complexity and anatomical location.

8. What are the signs of post-procedure complications?

Patients should be educated to report severe abdominal pain, fever, chills, or bloody stools immediately.

9. Can EFTR be used in the upper GI tract?

Yes, EFTR is applicable in the stomach, duodenum, and esophagus, though anatomical constraints vary by site.

10. Does the clip interfere with future MRI scans?

The nitinol clips are generally MRI-conditional; however, the radiologist should always be informed of the presence of metallic implants.


10. Conclusion

Endoscopic Full-Thickness Resection (EFTR) represents a significant advancement in interventional gastroenterology. By enabling the precise removal of deep-seated lesions with an integrated closure system, EFTR minimizes the need for traditional surgery and reduces patient downtime. However, the procedure demands rigorous patient selection, precise endoscopic technique, and a thorough understanding of the anatomical risks involved. As technology continues to evolve, we expect the indications for EFTR to expand, further cementing its role as a cornerstone of modern, minimally invasive gastrointestinal therapy.


Disclaimer: This guide is intended for educational purposes for clinical professionals. Clinical decision-making should always be based on individual patient assessment, local institutional guidelines, and the most current peer-reviewed evidence.

Related Medical Information

Surgical Instruments Used
Share this procedure: